Jackson, Grant Investment Advisers, Inc. Abb Vie Inc. Transaction History
Jackson, Grant Investment Advisers, Inc.
- $257 Million
- Q4 2024
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 31,134 shares of ABBV stock, worth $6 Million. This represents 2.15% of its overall portfolio holdings.
Number of Shares
31,134
Previous 30,849
0.92%
Holding current value
$6 Million
Previous $6.09 Million
9.19%
% of portfolio
2.15%
Previous 2.3%
Shares
31 transactions
Others Institutions Holding ABBV
# of Institutions
4,064Shares Held
1.28BCall Options Held
17.8MPut Options Held
15.7M-
Vanguard Group Inc Valley Forge, PA173MShares$33.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.98 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.65 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $341B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...